Tag: Promising
Roflumilast Promising for AD in Children Down to Age 3 Mos Medscape Source link
SINGAPORE – New treatments for skin conditions such as psoriasis, eczema, vitiligo and melasma were among the latest developments showcased at the 25th World Congress of Dermatology (WCD), the largest medical event ever held here, from last Monday to Saturday. Over the past decade, dermatology has been second only to cancer in terms of having […]
Eczema, also known as atopic dermatitis, is a chronic skin condition characterized by dry, itchy, and inflamed skin. It is a common condition that affects people of all ages, but it is most prevalent in infants and children. Eczema can cause the skin to become red, scaly, and crack, leading to discomfort, pain, and itchiness. […]
Dupilumab had an acceptable long-term safety and efficacy for adolescents with moderate to severe atopic dermatitis (AD), according to data from an open-label extension (OLE) phase 3 trial published in the American Journal of Clinical Dermatology. For adolescents (aged 12 to 18 years) with moderate to severe AD enrolled in the LIBERTY AD PED-OLE study, […]